Please check your internet connection and try again.
# Hyaluronic Acid
## Overview
Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in various tissues, including synovial fluid, skin, and connective tissue. It acts as a lubricant and shock absorber. Exogenous HA is often derived from bacterial fermentation or rooster combs.
## Primary Indications
* **Intra-articular injection:** Osteoarthritis of the knee (viscosupplementation).
* **Ophthalmic surgery:** Ophthalmic viscoelastic device (OVD) for cataract surgery, corneal transplantation, and other intraocular procedures.
* **Topical formulations:** Skin hydration and wound healing (limited evidence for efficacy).
## Adult Dosing
**Intra-articular Injection (Osteoarthritis of the knee):**
* **Common regimens:**
* Single injection: 60 mg (e.g., 6 mL of 10 mg/mL solution).
* Three weekly injections: 20 mg (e.g., 2 mL of 10 mg/mL solution) given once weekly for 3 weeks.
* Five weekly injections: 20 mg (e.g., 2 mL of 10 mg/mL solution) given once weekly for 5 weeks.
* **Maximum dose:** Varies by product and regimen. Follow manufacturer guidelines. Some products are labeled for a single injection of up to 60 mg.
**Ophthalmic Viscoelastic Device (OVD):**
* Dosage and administration are specific to the surgical procedure and the particular OVD formulation used. Typically administered intraocularly by a surgeon.
## Pediatric Dosing
Established pediatric dosing for intra-articular hyaluronic acid injections for osteoarthritis is generally **not available**. Use in pediatric patients requires careful consideration and consultation with specialists.
## Dose Adjustments
No specific dose adjustments are typically required for hepatic or renal impairment.
## Contraindications
* Known hypersensitivity to hyaluronic acid or any component of the formulation.
* Active joint infection or severe skin infection over the injection site.
* Intra-articular injection: Should not be administered if the knee is already infected.
## Adverse Effects
**Intra-articular Injection:**
* Pain, swelling, stiffness, or warmth at the injection site.
* Arthralgia.
* Rarely: Allergic reactions, joint effusion, transient inflammatory reactions.
**Ophthalmic Use:**
* Transient intraocular pressure elevation.
* Corneal clouding.
* Retinal detachment (rare).
## Key Drug Interactions
* **Intra-articular corticosteroids:** Concurrent injection may lead to more rapid degradation of hyaluronic acid. If co-administration is necessary, it is often recommended to inject the corticosteroid first.
* **Other intra-articular injections:** Avoid co-administration of multiple types of HA products or other intra-articular agents simultaneously unless specifically indicated by product labeling.
## Monitoring
* **Intra-articular Injection:** Monitor for signs and symptoms of infection, inflammation, or allergic reaction at the injection site. Assess pain and functional improvement of the knee.
* **Ophthalmic Use:** Post-operative monitoring by the ophthalmologist is crucial to assess intraocular pressure and other potential complications.
## Clinical Pearls
* Hyaluronic acid injections for osteoarthritis provide symptomatic relief, not a cure. Effects may take several weeks to become apparent and can last for months.
* Multiple injection regimens may offer prolonged relief for some patients.
* Proper sterile technique is essential during intra-articular administration to prevent infection.
* For ophthalmic use, the choice of OVD depends on the surgical procedure and surgeon preference.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information, drug compendia, and local protocols before making any treatment decisions. Dosing and administration can vary significantly based on the specific product, patient population, and clinical indication.